Wegovy (active ingredient semaglutide) and Manjaro (active ingredient tirzepatide), which have created a sensation in the obesity medication market worldwide, are also competing in the obesity ...

Share on Pinterest Researchers have compared the effectiveness of weight loss medications such as tirzepatide and semaglutide. Jaap Arriens/NurPhoto via Getty Images Tirzepatide and semaglutide are ...

MÁLAGA, Spain — In the first head-to-head trial of its kind, tirzepatide (Mounjaro for type 2 diabetes and Zepbound for obesity; Eli Lilly) produced significantly greater weight loss, and reduction in ...

Compounded tirzepatide contains the same active ingredient as Mounjaro but may differ in quality, ingredients, and dosage. The Food and Drug Administration (FDA) does not regulate its safety, ...

Using medications for weight loss is becoming more common. Doctors sometimes prescribe newer type 2 diabetes drugs to help with weight management. This use is “off-label,” meaning that doctors ...

A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 ...

New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12–15 May) and published in The Lancet shows that people who have lost weight using the maximum tolerated ...

Studies show tirzepatide leads to significantly more weight loss on average compared to semaglutide. Tirzepatide and semaglutide are both FDA-approved weekly injections for weight management and type ...

Obesity is a chronic disease that results in substantial global morbidity and mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic polypeptide and glucagon-like ...